These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34779250)

  • 1. Steps Toward Standardized In Vitro Assessment of Immunomodulatory Equine Mesenchymal Stromal Cells Before Clinical Application.
    Lee OJ; Koch TG
    Stem Cells Dev; 2022 Jan; 31(1-2):18-25. PubMed ID: 34779250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use.
    Torrents S; Del Moral AE; Codinach M; Rodríguez L; Querol S; Vives J
    Immunol Res; 2023 Oct; 71(5):725-734. PubMed ID: 37120479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
    Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A
    Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes.
    Ranera B; Antczak D; Miller D; Doroshenkova T; Ryan A; McIlwraith CW; Barry F
    Equine Vet J; 2016 Mar; 48(2):253-60. PubMed ID: 25582202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine Cord Blood Mesenchymal Stromal Cells Have Greater Differentiation and Similar Immunosuppressive Potential to Cord Tissue Mesenchymal Stromal Cells.
    Lepage SIM; Lee OJ; Koch TG
    Stem Cells Dev; 2019 Feb; 28(3):227-237. PubMed ID: 30484372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
    Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
    Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro.
    Connard SS; Linardi RL; Even KM; Berglund AK; Schnabel LV; Ortved KF
    Vet Immunol Immunopathol; 2021 Apr; 234():110203. PubMed ID: 33636546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.
    Colbath AC; Dow SW; Phillips JN; McIlwraith CW; Goodrich LR
    Stem Cells Dev; 2017 Apr; 26(7):503-511. PubMed ID: 27958776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pregnancy on isolation efficiency and in vitro proliferation of equine peripheral-blood derived mesenchymal stromal cells.
    Mattei DN; Harman RM; Van de Walle GR; Smith R; Grivel JC; Abdelalim EM; Vinardell T
    Theriogenology; 2024 Aug; 224():107-118. PubMed ID: 38761667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context- and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells.
    Hillmann A; Paebst F; Brehm W; Piehler D; Schubert S; Tárnok A; Burk J
    PLoS One; 2019; 14(6):e0218949. PubMed ID: 31247035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge.
    Boland LK; Burand AJ; Boyt DT; Dobroski H; Di L; Liszewski JN; Schrodt MV; Frazer MK; Santillan DA; Ankrum JA
    Front Immunol; 2019; 10():1080. PubMed ID: 31134100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs).
    Hsu PJ; Liu KJ; Chao YY; Sytwu HK; Yen BL
    J Vis Exp; 2015 Dec; (106):e53265. PubMed ID: 26780482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell.
    Hansen SB; Højgaard LD; Kastrup J; Ekblond A; Follin B; Juhl M
    Front Immunol; 2022; 13():1085312. PubMed ID: 36578497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to allogeneic equine mesenchymal stromal cells.
    Kamm JL; Riley CB; Parlane NA; Gee EK; McIlwraith CW
    Stem Cell Res Ther; 2021 Nov; 12(1):570. PubMed ID: 34772445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.
    Barrachina L; Cequier A; Romero A; Vitoria A; Zaragoza P; Vázquez FJ; Rodellar C
    Stem Cell Res Ther; 2020 Feb; 11(1):52. PubMed ID: 32028995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.